SK482001A3 - Cyclic compounds useful in the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process - Google Patents
Cyclic compounds useful in the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process Download PDFInfo
- Publication number
- SK482001A3 SK482001A3 SK48-2001A SK482001A SK482001A3 SK 482001 A3 SK482001 A3 SK 482001A3 SK 482001 A SK482001 A SK 482001A SK 482001 A3 SK482001 A3 SK 482001A3
- Authority
- SK
- Slovakia
- Prior art keywords
- group
- formula
- atóm
- alkyl
- aryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/08—1,3-Dioxanes; Hydrogenated 1,3-dioxanes condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9809164A FR2781222A1 (fr) | 1998-07-17 | 1998-07-17 | Composes cycliques utilisables dans le traitement de dyslipidemies, de l'atherosclerose et du diabete, compositions pharmaceutiques les contenant et procede de preparation |
| PCT/EP1999/004831 WO2000004011A1 (en) | 1998-07-17 | 1999-07-09 | Cyclic compounds useful in the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK482001A3 true SK482001A3 (en) | 2001-09-11 |
Family
ID=9528730
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK48-2001A SK482001A3 (en) | 1998-07-17 | 1999-07-09 | Cyclic compounds useful in the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6528538B1 (de) |
| EP (1) | EP1098893B1 (de) |
| JP (1) | JP2002520407A (de) |
| KR (1) | KR20010070966A (de) |
| CN (1) | CN1309655A (de) |
| AT (1) | ATE235485T1 (de) |
| AU (1) | AU753287B2 (de) |
| BR (1) | BR9912138A (de) |
| CA (1) | CA2337481A1 (de) |
| DE (1) | DE69906303T2 (de) |
| DK (1) | DK1098893T3 (de) |
| ES (1) | ES2192853T3 (de) |
| FR (1) | FR2781222A1 (de) |
| HK (1) | HK1039615A1 (de) |
| HU (1) | HUP0103411A3 (de) |
| ID (1) | ID27854A (de) |
| NO (1) | NO20010266D0 (de) |
| PL (1) | PL345397A1 (de) |
| PT (1) | PT1098893E (de) |
| SK (1) | SK482001A3 (de) |
| WO (1) | WO2000004011A1 (de) |
| ZA (1) | ZA200101303B (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI311133B (en) | 2001-04-20 | 2009-06-21 | Eisai R&D Man Co Ltd | Carboxylic acid derivativeand the salt thereof |
| JPWO2003016265A1 (ja) * | 2001-08-17 | 2004-12-02 | エーザイ株式会社 | 環状化合物およびｐｐａｒアゴニスト |
| RU2379303C2 (ru) | 2003-04-24 | 2010-01-20 | Инсайт Корпорейшн | Производные азаспироалканов в качестве ингибиторов металлопротеаз |
| WO2005077943A1 (en) * | 2004-01-09 | 2005-08-25 | Cadila Healthcare Limited | 1 , 3 - dioxane derivatives and analogues thereof useful in the treatment of i.a. obesity and diabetes |
| JP2008510696A (ja) * | 2004-08-20 | 2008-04-10 | カディラ ヘルスケア リミティド | 新規抗糖尿病化合物 |
| CN100389112C (zh) * | 2004-12-16 | 2008-05-21 | 中国石油化工股份有限公司 | 一类环状缩醛和缩酮化合物及其应用 |
| CA2633440C (en) * | 2006-02-27 | 2011-06-21 | Cadila Healthcare Limited | 1,3-dioxane carboxylic acids |
| JP2009537559A (ja) * | 2006-05-18 | 2009-10-29 | ウェルスタット セラピューティクス コーポレイション | 代謝障害の処置のための化合物 |
| US7910108B2 (en) * | 2006-06-05 | 2011-03-22 | Incyte Corporation | Sheddase inhibitors combined with CD30-binding immunotherapeutics for the treatment of CD30 positive diseases |
| WO2016056031A1 (en) | 2014-10-08 | 2016-04-14 | Council Of Scientific & Industrial Research | Novel diol compounds synthesis and its use for formal synthesis of (2r, 3 s)-3-hydroxypipecolic acid |
| US9637575B2 (en) * | 2014-12-31 | 2017-05-02 | W. R. Grace & Co. -Conn. | Catalyst system, olefin polymerization catalyst components comprising at least an internal electron donor compound, and methods of making and using the same |
| US20230050418A1 (en) * | 2019-12-13 | 2023-02-16 | Rhodia Operations | Production of benzene derivatives |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4032536A (en) | 1976-07-22 | 1977-06-28 | Janssen Pharmaceutica N.V. | (1h-benzimidazol-2-yl)carbamates |
| US5179216A (en) * | 1990-08-16 | 1993-01-12 | American Home Products Corporation | N,n', n'-trisubstituted-5-bisaminomethylene-1,3-dioxane-4,6-dione inhibitors of acyl-coa:cholesterol-acyl transferase |
| TW209868B (de) * | 1991-04-04 | 1993-07-21 | Yoshitomi Pharmaceutical | |
| DE19637840A1 (de) * | 1996-09-17 | 1998-03-19 | Henkel Kgaa | Verwendung von geminalen Dialkoxyalkansäureestern zur Herstellung von desodorierenden Körperpflegemitteln |
-
1998
- 1998-07-17 FR FR9809164A patent/FR2781222A1/fr not_active Withdrawn
-
1999
- 1999-07-09 US US09/743,759 patent/US6528538B1/en not_active Expired - Fee Related
- 1999-07-09 ES ES99934643T patent/ES2192853T3/es not_active Expired - Lifetime
- 1999-07-09 HU HU0103411A patent/HUP0103411A3/hu unknown
- 1999-07-09 CN CN99808783A patent/CN1309655A/zh active Pending
- 1999-07-09 EP EP99934643A patent/EP1098893B1/de not_active Expired - Lifetime
- 1999-07-09 PL PL99345397A patent/PL345397A1/xx unknown
- 1999-07-09 KR KR1020017000647A patent/KR20010070966A/ko not_active Application Discontinuation
- 1999-07-09 PT PT99934643T patent/PT1098893E/pt unknown
- 1999-07-09 AT AT99934643T patent/ATE235485T1/de not_active IP Right Cessation
- 1999-07-09 WO PCT/EP1999/004831 patent/WO2000004011A1/en not_active Application Discontinuation
- 1999-07-09 SK SK48-2001A patent/SK482001A3/sk unknown
- 1999-07-09 BR BR9912138-7A patent/BR9912138A/pt not_active IP Right Cessation
- 1999-07-09 DK DK99934643T patent/DK1098893T3/da active
- 1999-07-09 AU AU50347/99A patent/AU753287B2/en not_active Ceased
- 1999-07-09 CA CA002337481A patent/CA2337481A1/en not_active Abandoned
- 1999-07-09 DE DE69906303T patent/DE69906303T2/de not_active Expired - Fee Related
- 1999-07-09 ID IDW20010261A patent/ID27854A/id unknown
- 1999-07-09 JP JP2000560117A patent/JP2002520407A/ja active Pending
-
2001
- 2001-01-16 NO NO20010266A patent/NO20010266D0/no not_active Application Discontinuation
- 2001-02-15 ZA ZA200101303A patent/ZA200101303B/en unknown
-
2002
- 2002-02-07 HK HK02100966.8A patent/HK1039615A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200101303B (en) | 2002-05-15 |
| AU753287B2 (en) | 2002-10-17 |
| HK1039615A1 (zh) | 2002-05-03 |
| ATE235485T1 (de) | 2003-04-15 |
| BR9912138A (pt) | 2001-04-10 |
| PL345397A1 (en) | 2001-12-17 |
| US6528538B1 (en) | 2003-03-04 |
| DE69906303D1 (de) | 2003-04-30 |
| ES2192853T3 (es) | 2003-10-16 |
| EP1098893B1 (de) | 2003-03-26 |
| DK1098893T3 (da) | 2003-07-07 |
| AU5034799A (en) | 2000-02-07 |
| CA2337481A1 (en) | 2000-01-27 |
| NO20010266L (no) | 2001-01-16 |
| HUP0103411A3 (en) | 2002-08-28 |
| JP2002520407A (ja) | 2002-07-09 |
| PT1098893E (pt) | 2003-08-29 |
| HUP0103411A2 (hu) | 2002-04-29 |
| FR2781222A1 (fr) | 2000-01-21 |
| CN1309655A (zh) | 2001-08-22 |
| ID27854A (id) | 2001-04-26 |
| NO20010266D0 (no) | 2001-01-16 |
| EP1098893A1 (de) | 2001-05-16 |
| DE69906303T2 (de) | 2003-12-11 |
| KR20010070966A (ko) | 2001-07-28 |
| WO2000004011A1 (en) | 2000-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2293563T3 (es) | Derivados del acido hexenoico, procesos para su preparacion, composiciones farmaceuticas que los contengan y su aplicacion terapeutica. | |
| AU2008229824A1 (en) | Compounds for the treatment of metabolic disorders | |
| AU2009258040B2 (en) | Compounds and method for reducing uric acid | |
| SK482001A3 (en) | Cyclic compounds useful in the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process | |
| WO2000063196A1 (en) | New compounds, their preparation and use | |
| FR2787789A1 (fr) | Benzopyranes et benzoxepines utilisables dans le traitement de dyslipidemies, de l'atherosclerose et du diabete, compositions pharmaceutiques les contenant et procedes de preparations | |
| JP2004501076A (ja) | 新規化合物、それらの製造及び使用 | |
| AU658023B2 (en) | Substituted phenyl phenol leukotriene antagonists | |
| LU81300A1 (fr) | Derives d'hydantoine,procede pour leur preparation et application de ces composes comme medicaments | |
| IE64243B1 (en) | Derivatives of benzocycloalkenyldihydroxyalkanoic acids processes of preparation and medications containing them | |
| US6274608B1 (en) | Compounds, their preparation and use | |
| US5780675A (en) | Deoxygossylic compounds | |
| JP2003520839A (ja) | 新規化合物、それらの製造及び使用 | |
| US5391569A (en) | New chromene compounds having a triene side chain | |
| AU2005238141B2 (en) | Pentenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof | |
| JPH05194460A (ja) | ロイコトリエン拮抗物質製造用エポキシド中間体 | |
| EP0068563A2 (de) | Heterocyclische Essigsäureverbindungen und Zusammensetzungen zur Behandlung von Knochenkrankheiten | |
| FR2791982A1 (fr) | Inhibiteurs de lta4 hydrolase et leurs applications therapeutiques. | |
| FR2849849A1 (fr) | Nouveaux acides carboxyliques et derives pour le traitement et la prevention du diabete et des dyslipemies | |
| MXPA01000562A (en) | Cyclic compounds useful in the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process | |
| CZ2001195A3 (cs) | Cyklické sloučeniny vhodné k léčení dyslipidemie, atherosklerózy a diabetes, způsob jejich přípravy a farmaceutické prostředky, které je obsahují | |
| US4013692A (en) | Certain 3-phenyl-benzofuran lower alkanoic acids and esters thereof | |
| JP4486499B2 (ja) | 糖尿病、脂質代謝異常およびアテローム性動脈硬化症の治療および予防に使用できる新規な置換アリールへキサジエン酸およびそのエステル、これらを含有する医薬組成物、ならびにこれらの調製方法 | |
| BE820920A (fr) | Acides (1-hydroxy-5-indanyloxy- (ou thio))-alcanoiques et procedes pour leur preparation |